Anika Closes Divestiture Of Its Arthrosurface Business And Intention To Divest Of Parcus Medical Business

Anika Therapeutics, Inc. +0.17%

Anika Therapeutics, Inc.

ANIK

17.26

+0.17%

The sale of the Company's Arthrosurface business to Phoenix Brio, Incorporated closed today, October 31, 2024. The Company received consideration of $10 million in the form of a ten year non-interest bearing promissory note for $7 million, and an estimated $3 million of additional consideration subject to the sales performance of Arthrosurface.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via